Sandwich, United Kingdom

Christopher Pickford

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Christopher Pickford

Introduction

Christopher Pickford is a notable inventor based in Sandwich, GB. He has made significant contributions to the field of therapeutics, particularly in the development of novel compounds aimed at treating serious health conditions. With a total of 2 patents to his name, Pickford's work is paving the way for advancements in medical treatments.

Latest Patents

Pickford's latest patents focus on compounds and their therapeutic uses. The first patent relates to novel compounds that can link an immune response to a defined therapeutic target. This invention is particularly relevant for treating cancer and infectious diseases. The second patent also addresses similar compounds, emphasizing their use in treating diseases or disorders caused by infective agents. Both patents include details on the compositions containing these compounds, processes for their preparation, and novel intermediates used in these processes.

Career Highlights

Throughout his career, Christopher Pickford has worked with various companies, including Centuari Therapeutics Limited and Avvinity Therapeutics Limited. His experience in these organizations has allowed him to collaborate with other professionals in the field and contribute to groundbreaking research.

Collaborations

Some of Pickford's notable coworkers include Christine Watson and Melanie Glossop. Their collaborative efforts have likely enhanced the innovative processes and research outcomes in which they have been involved.

Conclusion

Christopher Pickford's contributions to the field of therapeutics through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of treatments for critical health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…